Victoria A. Khotina

8, Baltiiskaya Street
Moscow, MOW 125315, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact.

Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact.

Journal: Medical sciences (Basel, Switzerland)
Published: September 30, 2025

Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications.

Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications.

Journal: International journal of molecular sciences
Published: July 17, 2025

Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice.

Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice.

Journal: Antibiotics (Basel, Switzerland)
Published: March 12, 2025

Preclinical Evaluation of the Safety, Toxicity and Efficacy of Genetically Modified Wharton's Jelly Mesenchymal Stem/Stromal Cells Expressing the Antimicrobial Peptide SE-33.

Preclinical Evaluation of the Safety, Toxicity and Efficacy of Genetically Modified Wharton's Jelly Mesenchymal Stem/Stromal Cells Expressing the Antimicrobial Peptide SE-33.

Journal: Cells
Published: January 14, 2025

Cells with Defective Mitophagy Do Not Accumulate Atherogenic LDL-Derived Cholesterol.

Cells with Defective Mitophagy Do Not Accumulate Atherogenic LDL-Derived Cholesterol.

Journal: Current medicinal chemistry
Published: August 14, 2024

Mitochondrial DNA Mutations as a Factor in the Heritability of Atherosclerosis and Other Diseases.

Mitochondrial DNA Mutations as a Factor in the Heritability of Atherosclerosis and Other Diseases.

Journal: Current medicinal chemistry
Published: July 07, 2024

Mitochondrial Dysfunction Associated with mtDNA Mutation: Mitochondrial Genome Editing in Atherosclerosis Research.

Mitochondrial Dysfunction Associated with mtDNA Mutation: Mitochondrial Genome Editing in Atherosclerosis Research.

Journal: Current medicinal chemistry
Published: May 13, 2024

The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger.

The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger.

Journal: Current atherosclerosis reports
Published: April 30, 2024

Non-rodent Models of Atherosclerosis: Repurposing of Existing Drugs and Search for Novel Treatment Strategies.

Non-rodent Models of Atherosclerosis: Repurposing of Existing Drugs and Search for Novel Treatment Strategies.

Journal: Current cardiology reviews
Published: April 05, 2024

Non-oxidative vs Oxidative Forms of Modified Low-density Lipoprotein: What is More Important in Atherogenesis?

Non-oxidative vs Oxidative Forms of Modified Low-density Lipoprotein: What is More Important in Atherogenesis?

Journal: Current medicinal chemistry
Published: November 21, 2023

Evidence for the Involvement of Gene Regulation of Inflammatory Molecules in the Accumulation of Intracellular Cholesterol: The Mechanism of Foam Cell Formation in Atherosclerosis.

Evidence for the Involvement of Gene Regulation of Inflammatory Molecules in the Accumulation of Intracellular Cholesterol: The Mechanism of Foam Cell Formation in Atherosclerosis.

Journal: Current medicinal chemistry
Published: November 03, 2023

Mitochondrial Genome Editing: Exploring the Possible Relationship of the Atherosclerosis-Associated Mutation m.15059G>A With Defective Mitophagy.

Mitochondrial Genome Editing: Exploring the Possible Relationship of the Atherosclerosis-Associated Mutation m.15059G>A With Defective Mitophagy.

Journal: Journal of lipid and atherosclerosis
Published: October 16, 2023
Showing 1-12 of 34

Last Updated: 09/26/2026